A Cost-Effectiveness Model Comparing Rivaroxaban and Dabigatran Etexilate with Enoxaparin Sodium as Thromboprophylaxis after Total Hip and Total Knee Replacement in the Irish Healthcare Setting

被引：0
|
作者：
Laura McCullagh
Lesley Tilson
Cathal Walsh
Michael Barry
机构：
[1] St James’s Hospital,National Centre for Pharmacoeconomics
[2] Trinity College Dublin,Department of Statistics
来源：
PharmacoEconomics | 2009年 / 27卷
关键词：
Deep Venous Thrombosis; Dabigatran; Rivaroxaban; Total Knee Replacement; Probabilistic Sensitivity Analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: It has been estimated that major orthopaedic surgery has the highest risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) when compared with other surgery. Two new orally active anticoagulants have recently become licensed in Ireland for the primary prevention of venous thromboembolism in adult patients undergoing elective total hip replacement (THR) or total knee replacement (TKR). Rivaroxaban (Xarelto®) is a direct factor Xa inhibitor and dabigatran etexilate (Pradaxa®) is a prodrug of the active compound dabigatran, which inhibits thrombin.
引用
收藏
页码：829 / 846
页数：17
相关论文
共 50 条
  • [31] A SOCIETAL PERSPECTIVE COST-UTILITY ANALYSIS OF RIVAROXABAN COMPARED WITH ENOXAPARIN SODIUM IN PATIENTS UNDERGOING TOTAL HIP OR TOTAL KNEE REPLACEMENT SURGERY
    Stollenwerk, B.
    Le, L.
    Zindel, S.
    Mueller, D.
    Klug, F.
    Stock, S.
    VALUE IN HEALTH, 2013, 16 (07) : A530 - A530
  • [32] Economic Evaluation of Dabigatran Etexilate for the Prevention of Venous Thromboembolism After Total Knee and Hip Replacement Surgery
    Wolowacz, Sorrel E.
    Roskell, Neil S.
    Maciver, Fiona
    Beard, Stephen M.
    Robinson, Paul A.
    Plumb, Jonathan M.
    Dolan, Gerry
    Brenkel, Ivan J.
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 194 - 212
  • [33] RECORD2: extended thromboprophylaxis with rivaroxaban versus short-term thromboprophylaxis with enoxaparin after total hip replacement
    Kakkar, A. K.
    Brenner, B.
    Dahl, O. E.
    Eriksson, B. I.
    Mouret, P.
    Muntz, J.
    Bandel, T. J.
    Misselwitz, F.
    Haas, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 65 - 65
  • [34] Oral rivaroxaban versus subcutaneous enoxaparin for extended thromboprophylaxis after total hip replacement: RECORD1
    Eriksson, B. I.
    Borris, L. C.
    Friedman, R. J.
    Haas, S.
    Huisman, M. V.
    Kakkar, A. K.
    Bandel, T. J.
    Muehlhofer, E.
    Misselwitz, F.
    Geerts, W.
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 141 : 82 - 82
  • [35] Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review
    Asma Rashki Kemmak
    Ali Abutorabi
    Vahid Alipour
    Clinical Drug Investigation, 2020, 40 : 715 - 725
  • [36] Economic Evaluation of Rivaroxaban Versus Enoxaparin for Prevention of Venous Thromboembolism After Total Knee Replacement and Total Hip Replacement: A Systematic Review
    Rashki Kemmak, Asma
    Abutorabi, Ali
    Alipour, Vahid
    CLINICAL DRUG INVESTIGATION, 2020, 40 (08) : 715 - 725
  • [37] Cost-effectiveness of dabigatran etexilate in Canada for the primary prevention of venous thromboembolism (VTE) in patients undergoing total knee replacement surgery (TKR)
    Bradley-Kennedy, C.
    Wolowacz, S. E.
    Roskell, N. S.
    Plumb, J. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 786 - 786
  • [38] Rivaroxaban for Thromboprophylaxis After Total Hip or Knee Replacement Surgery: Comparison of Outcomes of the XAMOS and RECORD Studies
    Turpie, Alexander G. G.
    Schmidt, Andre
    Lassen, Michael Rud
    Mantovani, Lorenzo
    Kreutz, Reinhold
    Holberg, Gerlind
    Haas, Sylvia
    BLOOD, 2012, 120 (21)
  • [39] RIVAROXABAN FOR THROMBOPROPHYLAXIS AFTER TOTAL HIP OR KNEE REPLACEMENT SURGERY: COMPARISON OF OUTCOMES OF THE XAMOS AND RECORD STUDIES
    Turpie, Alexander G. G.
    Schmidt, Andre
    Lassen, Michael R.
    Mantovani, Lorenzo G.
    Kreutz, Reinhold
    Holberg, Gerlind
    Haas, Sylvia
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (06) : E74 - E75
  • [40] Dabigatran Etexilate A Review of its Use for the Prevention of Venous Thromboembolism after Total Hip or Knee Replacement Surgery
    Burness, Celeste B.
    McKeage, Kate
    DRUGS, 2012, 72 (07) : 963 - 986
12345